Tue Jul 01 21:40:00 UTC 2025: Here’s a news article summarizing and rewriting the provided text:

**Oscar Health Shares Soar, Analyst Predicts Fivefold Increase as Disruptive Approach Gains Traction**

**NEW YORK, NY** – Shares of Oscar Health (OSCR) are riding high, having jumped 50% in the last six months, and one analyst believes the rally is just beginning. Ray Myers, author of the Global Equity Briefing investment blog, sees Oscar as a “health insurance disruptor” poised for significant growth, potentially increasing its share price fivefold.

Myers argues that Oscar’s innovative approach to healthcare differentiates it from traditional insurers, who primarily act as claims processors. Oscar, on the other hand, focuses on directly engaging with patients and doctors to improve health outcomes and reduce costs. A key element of this strategy is integration with Oscar Medical Group, which provides medical services exclusively to Oscar Health members. The Oscar app, lauded for its user-friendly design and personalized health insights, has received overwhelmingly positive reviews, further demonstrating the company’s patient-centric focus.

This unique approach is paying off, with Oscar Health achieving profitability for the first time in 2024, reporting an annual net income of $25.4 million after a $270 million loss the previous year. This success has continued into the first quarter of 2025, with a reported 42% increase in revenue, reaching $3.046 billion, and net income of $275 million. The company’s membership base is also expanding rapidly, reaching approximately 2 million health plan members, a 40% increase year-over-year.

Analysts are bullish on Oscar’s future, projecting continued revenue and earnings growth. Myers believes that the company’s operational efficiencies will drive significant profitability, with net income projected to surge by over 2,300% in the next three years. Wall Street anticipates a 22.5% increase in revenue this year and over 42% by 2027. Overall, earnings are expected to grow 24-fold over the next three years.

Despite a high trailing 12-month P/E ratio, Myers considers Oscar Health, currently trading around $20 with a market cap of $5.2 billion, to be “attractively priced,” suggesting a strong potential for future gains.

**Key Takeaways:**

* Oscar Health shares have risen 50% in the last six months.
* One analyst believes Oscar’s share price could increase fivefold.
* The company achieved profitability for the first time in 2024 and continues to show growth.
* Analysts project strong revenue and earnings growth for Oscar Health in the coming years.

Read More